Watch for symptoms of hypoglycemia: shakiness, sweating, confusion, rapid heartbeat
Moreover, semaglutide has been shown to improve other metabolic parameters, including blood pressure and lipid profiles
The physical sensation of a properly administered subcutaneous injection is genuinely minimal, often less than a mosquito bite
Most patients see noticeable improvements within 3 to 6 weeks after the treatment, with final results typically visible after three months as the swelling and bruising completely diminish
To overcome this limitation, synthetic GLP-1 analogues like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide have been developed
Weekly subcutaneous injections (similar to insulin pens) Dosing starts low and gradually increases No sedation or downtime required Ideal for adults with: BMI 30 (obesity) or BMI 27 + weight-related conditions (e.g., diabetes, hypertension) Not recommended for pregnant women or those with certain endocrine disorders